Today, Baby Giants Investing Podcast released a wide ranging interview with Pro Medicus CEO, Dr Sam Hupert, shedding new light on elements of the company’s AI strategy and competitive positioning, among a wide range of subjects.
For example, this Pro Medicus CEO interview, explores subject of AI in radiology. Pro Medicus CEO Sam Hupert said:
“I think everybody believes AI will become mainstream and will become part of healthcare and healthcare imaging in particular. I think there are a number of ways that could occur and all of them are plausible…”
Given this uncertainty, Pro Medicus wants “not one but multiple seats at the table so that if it moves in one direction, maybe earlier than another we’re at least what I call in the slot ready for that.”
In practice, that means “developing our own [algorithms]. Doing things with academic partners, doing things with third parties, but most importantly, the platform itself is AI ready… AI in radiology is showing you something that overlays on top of an image and we can actually build that into the core product so you don’t need pop-ups and things.”
This Pro Medicus CEO Interview also touched explored the competitive environment for Pro Medicus.
Regarding Pro Medicus’ competition, CEO Sam Hupert said:
“You need competition to keep you sharp. I think the overriding theme is that the large equipment vendors that used to work aggressively in the space, people like GE and Siemens, have largely stopped… Siemens are telling the market that they’re bringing out a new platform. The only one of the big equipment manufacturers that is really active is Philips. They doubled down and bought Carestream, which was the old Kodak…. [But] I think the main competition we have is from independent software houses like ourselves, at this point.”
He also explained that “…there’s a lot of what I call the small guys waiting in the pond, [trying to work with] the Amazons and Microsoft… And now with Cloud, they have a very good reason to be there. At the moment, that’s all complementary to what we’re doing. And I would assume it’ll stay that way. So most of the competition is really independent.”
You can listen to the Baby Giants Investing Podcast Sam Hupert CEO Interview, below:
Disclosure: The author of this article owns shares in Pro Medicus and will not trade them for at least 2 days following the publication of this article.
Sign Up To Our Free Newsletter
This article is not intended to form the basis of an investment decision. Any statements that are advice under the law are general advice only. The author has not considered your investment objectives or personal situation. Any advice is authorised by Claude Walker (AR 1297632), Authorised Representative of Equity Story Pty Ltd (ABN 94 127 714 998) (AFSL 343937).
The information contained in this report is not intended as and shall not be understood or construed as personal financial product advice. You should consider whether the advice is suitable for you and your personal circumstances. Before you make any decision about whether to acquire a certain product, you should obtain and read the relevant product disclosure statement. Nothing in this report should be understood as a solicitation or recommendation to buy or sell any financial products. Equity Story Pty Ltd and BlueTree Equity Pty Ltd t/a A Rich Life do not warrant or represent that the information, opinions or conclusions contained in this report are accurate, reliable, complete or current. Future results may materially vary from such opinions, forecasts, projections or forward looking statements. You should be aware that any references to past performance does not indicate or guarantee future performance.